5th Annual Cancer Risk and Prevention Symposium

Friday, May 8, 2026

7:15 a.m. – 3:30 p.m.

The 5th Annual Cancer Risk and Prevention Symposium, sponsored by the Fred & Pamela Buffett Cancer Center, brings together multidisciplinary health care professionals to review advances in hereditary cancer risk assessment, genetic evaluation, and precision prevention. The 2026 program focuses on inherited cancer syndromes across solid tumors and hematologic malignancies, with sessions covering updates on Lynch syndrome, Li-Fraumeni syndrome, hereditary hematologic cancers, dermatologic clues to genetic risk, complex family history cases, and practical guidance on breast imaging, screening selection, and legal considerations related to genetic testing. Expert-led, case-based discussions and patient perspectives highlight strategies to translate genetic risk information into coordinated, equitable, and patient-centered prevention and screening practices.

Attendance Options

In-Person Location

Scott Conference Center
6450 Pine Street
Omaha, NE 68106

Virtual Attendance

Available via Zoom livestream
Instructions on how to join the livestream will be sent to registered participants via email a few days before the start of the symposium.

At the conclusion of this activity, participants should be better able to:

Identify patients at increased hereditary cancer risk using clinical features, family history patterns, dermatologic findings, and early-onset cancers to guide appropriate genetic evaluation and referral.
Apply risk-based cancer screening and surveillance principles, including breast imaging options and syndrome-specific considerations, to support personalized prevention and early detection.
Integrate effective communication, shared decision-making, and interdisciplinary collaboration, along with ethical and legal considerations related to genetic testing and discrimination, to support patient engagement and screening adherence.

This accredited continuing education activity is designed for primary care/internal medicine providers, advanced practice providers, genetic counselors, nurses, scientists, and other members of the cancer research teams who have an interest in familial cancer, hereditary cancer syndromes, and cancer prevention.

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
The University of Nebraska Medical Center designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The University of Nebraska Medical Center designates this activity for 6.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.

Genetic Counselors
This activity is pending National Society of Genetic Counselors (NSGC) approval for credit.

Registration Information

Registration Fees

Physicians: $100
Other Health Care Professionals: $50
UNMC/Nebraska Medicine Employees: Free

Deadline for registration: May 1, 2026

Payment Options

Credit/Debit Card: Credit and debit card payments are accepted. A $3 non-refundable processing fee will apply.
E-Check/ACH Transfer: Electronic check (ACH) payments are strongly recommended and do not incur any additional fees.

If you need assistance with online registration, please call our Registration Office at 402-559-5929.

Cancellation and Refund Policy

If you need to cancel your registration, please email registrationCCE@unmc.edu no later than May 1, 2026. A $25 processing fee will apply to cancellations received by this date. Please note that if you paid by credit or debit card, the $3 card processing fee is non-refundable. Cancellations made after May 1, as well as registrants who do not attend, are responsible for the full registration fee.

Symposium Directors

Kelsey Klute, MD

Associate Professor, Division of Medical Oncology, Department of Internal Medicine, UNMC
Medical Director, Cancer Risk and Prevention Clinic, Nebraska Medicine

Gwen Reiser, MS, CGC

Assistant Professor

Department of Genetic Medicine, Munroe-Meyer Institute, UNMC

Rachael Schmidt, DNP, FNP-C, AOCNP®

Program Director, Cancer Survivorship/Cancer Risk and Prevention; Assistant Director, Cancer Education and Screening, Buffett Cancer Center Community Outreach & Engagement Office, Nebraska Medicine

Sponsor

This symposium is sponsored by

Fred & Pamela Buffett Cancer Center

through the resources of the UNMC Center for Continuing Education and the UNMC College of Nursing Continuing interProfessional Development and Innovation (CiPDI).

Questions?

Missy Edwards

Educational Projects Coordinator

Center for Continuing Education, UNMC

Send Email

Phone: 402-559-5145